from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2407/-

LFCtreatmentdescriptionclass of inhibitor

0.187

Amikacinug/mL Amikacintranslation

0.463

Cap5-10ug/mL Capreomycintranslation

0.824

Rox10-50 ug/mL Roxithromycintranslation

1.610

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.142

Rif0.2-5ug/mL Rifampicintranscription

0.331

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.744

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.181

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.191

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.733

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.268

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.065

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.219

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.341

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.176

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.412

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.514

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.988

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.192

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.913

KCN5-20 ug/mL Potassium cyaniderespiration

-0.187

NaN30.2-2 mM Sodium aziderespiration

-1.268

Nigericin50 uM Nigericinrespiration

0.066

TRC10-150 ug/mL Triclosanrespiration

0.618

TRZ10-25 ug/mL Thioridazinerespiration

-0.978

Valinomycin0.5-10 uM Valinomycinrespiration

0.876

ZnSO42 mM ZnSO4respiration

-0.255

menadione6-10 ug/mL Menadionerespiration

-0.349

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.216

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.005

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.274

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.207

NRP_1Non-replicating persistence stage 1dosRassociated

0.101

Amp0.2mg/mL AmpicillincellWall

-0.221

Cephalexin20-100 ug/mL CephalexincellWall

-0.047

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.090

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.132

EMB10-20 ug/mL EthambutolcellWall

-0.023

Eta12-40 ug/mL EthionamidecellWall

-0.267

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.263

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.990

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.004

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.731

BZA0.12 mg/mL BenzamidearomaticAmides

0.026

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.018

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.252

H2O24 mM hydrogen peroxideDNAdamaging

-0.245

Levo10 ug/mL LevofloxacinDNAdamaging

0.505

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.368

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.153

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.589

UVUV-irradiationDNAdamaging

-0.955

ARP41-4 ug/mL Antitubercular compound ARP4?

-2.021

Antimycin12.5-50 ug/mL Antimycin A?

-0.477

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.805

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.155

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.314

PA8240.2-2 ug/mL PA-824?

-1.037

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.109

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.806

Verapamil50 uM Verapamil?

-0.203

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.729

methoxatin10-20 ug/mL Methoxatin?